In Brief This Week: PerkinElmer; Guardant Health; PacBio; BGI Tech; Thermo Fisher, UCSD; Fluidigm; Cynvenio; and More | GenomeWeb

NEW YORK (GenomeWeb) – Fitch Ratings this week affirmed three of its BBB- ratings for PerkinElmer. The ratings were affirmed for the company's issuer default rating, its credit facility, and its senior unsecured notes. Additionally, Fitch revised PerkinElmer's ratings outlook to Positive from Stable. The rating action applies to about $858 million of consolidated debt outstanding as of June 30.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.